AIM ImmunoTech Inc. (AIM) Return on equity 2016–2023
AIM ImmunoTech Inc. (AIM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-283.0%FY2023 · since FY2016: -48.4% → -283.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -283.0% | -232.4 pp |
| FY2022 | -50.5% | -16.9 pp |
| FY2021 | -33.6% | -10.1 pp |
| FY2020 | -23.5% | +46.5 pp |
| FY2019 | -70.0% | +106.2 pp |
| FY2018 | -176.1% | -81.2 pp |
| FY2017 | -94.9% | -46.5 pp |
| FY2016 | -48.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice